Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Peter, van der Ley"'
Autor:
Virgil Schijns, Dragomira Majhen, Peter van der Ley, Aneesh Thakur, Artur Summerfield, Rita Berisio, Cristina Nativi, Alberto Fernández-Tejada, Carmen Alvarez-Dominguez, Sveinbjörn Gizurarson, Alla Zamyatina, Antonio Molinaro, Camillo Rosano, Žiga Jakopin, Ihsan Gursel, Siobhán McClean
Publikováno v:
Pharmaceutics, Vol 13, Iss 4, p 501 (2021)
Vaccines are the most effective medical intervention due to their continual success in preventing infections and improving mortality worldwide. Early vaccines were developed empirically however, rational design of vaccines can allow us to optimise th
Externí odkaz:
https://doaj.org/article/0249c99acc3545c8937b3a2a29d22191
Autor:
Jesús Arenas, Elder Pupo, Coen Phielix, Dionne David, Afshin Zariri, Alla Zamyatina, Jan Tommassen, Peter van der Ley
Publikováno v:
Vaccines, Vol 8, Iss 4, p 594 (2020)
Whooping cough, or pertussis, is an acute respiratory infectious disease caused by the Gram-negative bacterium Bordetella pertussis. Whole-cell vaccines, which were introduced in the fifties of the previous century and proved to be effective, showed
Externí odkaz:
https://doaj.org/article/20bfbbe2c0ae4a96b351122682a80f4b
Publikováno v:
microLife. 3
Lipopolysaccharide (LPS) is for most but not all Gram-negative bacteria an essential component of the outer leaflet of the outer membrane. LPS contributes to the integrity of the outer membrane, which acts as an effective permeability barrier to anti
Publikováno v:
Analytical chemistry. 93(48)
The variable modification of the outer membrane lipopolysaccharide (LPS) in Gram-negative bacteria contributes to bacterial pathogenesis through various mechanisms, including the development of antibiotic resistance and evasion of the immune response
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
The development of more effective, accessible, and easy to administer COVID-19 vaccines next to the currently marketed mRNA, viral vector, and whole inactivated virus vaccines is essential to curtailing the SARS-CoV-2 pandemic. A major concern is red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3261a54dcdbe0843ff6386a6e3e482
https://doi.org/10.1101/2021.08.25.457644
https://doi.org/10.1101/2021.08.25.457644
Autor:
Tom Sprong, Mihai G. Netea, Peter van der Ley, Trees J.G. Verver-Jansen, Liesbeth E.H. Jacobs, Anton Stalenhoef, Jos W.M. van der Meer, Marcel van Deuren
Publikováno v:
Journal of Lipid Research, Vol 45, Iss 4, Pp 742-749 (2004)
The use of lipoproteins has been suggested as a treatment for Gram-negative sepsis because they inhibit lipopolysaccharide (LPS)-mediated cytokine production. However, little is known about the neutralizing effects of lipoproteins on cytokine product
Externí odkaz:
https://doaj.org/article/f14ca0d433f7445bb238358b7c1f9656
Autor:
Alla Zamyatina, Antonio Molinaro, Cristina Nativi, Alberto Fernández-Tejada, Ihsan Gursel, Aneesh Thakur, Carmen Alvarez-Dominguez, Siobhán McClean, Peter van der Ley, Artur Summerfield, Camillo Rosano, Dragomira Majhen, Virgil E.J.C. Schijns, Sveinbjörn Gizurarson, Žiga Jakopin, Rita Berisio
Publikováno v:
Schijns, Virgil; Majhen, Dragomira; van der Ley, Peter; Thakur, Aneesh; Summerfield, Artur; Berisio, Rita; Nativi, Cristina; Fernández-Tejada, Alberto; Alvarez-Dominguez, Carmen; Gizurarson, Sveinbjörn; Zamyatina, Alla; Molinaro, Antonio; Rosano, Camillo; Jakopin, Žiga; Gursel, Ihsan; McClean, Siobhán (2021). Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. Pharmaceutics, 13(4) MDPI 10.3390/pharmaceutics13040501
Pharmaceutics
Pharmaceutics, Vol 13, Iss 501, p 501 (2021)
Schijns, V, Majhen, D, Van Der Ley, P, Thakur, A, Summerfield, A, Berisio, R, Nativi, C, Fernández-tejada, A, Álverez-dominguez, C, Gizurarson, S, Zamyatina, A, Molinaro, A, Rosano, C, Jakopin, Ž, Gursel, I & Mcclean, S 2021, ' Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation ', Pharmaceutics, vol. 13, no. 4, 501 . https://doi.org/10.3390/pharmaceutics13040501
Pharmaceutics
Pharmaceutics, Vol 13, Iss 501, p 501 (2021)
Schijns, V, Majhen, D, Van Der Ley, P, Thakur, A, Summerfield, A, Berisio, R, Nativi, C, Fernández-tejada, A, Álverez-dominguez, C, Gizurarson, S, Zamyatina, A, Molinaro, A, Rosano, C, Jakopin, Ž, Gursel, I & Mcclean, S 2021, ' Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation ', Pharmaceutics, vol. 13, no. 4, 501 . https://doi.org/10.3390/pharmaceutics13040501
Vaccines are the most effective medical intervention due to their continual success in preventing infections and improving mortality worldwide. Early vaccines were developed empirically however, rational design of vaccines can allow us to optimise th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ab37e2248edd84bf4a4d441bb02f43
https://boris.unibe.ch/157742/1/b157742.pdf
https://boris.unibe.ch/157742/1/b157742.pdf
Autor:
Manish Sadarangani, J. Claire Hoe, Martin J. Callaghan, Claire Jones, Hannah Chan, Katherine Makepeace, Hélène Daniels-Treffandier, Mary E. Deadman, Christopher Bayliss, Ian Feavers, Peter van der Ley, Andrew J. Pollard
Publikováno v:
PLoS ONE, Vol 8, Iss 10 (2013)
Externí odkaz:
https://doaj.org/article/40a3ee41a3d94954b8df946c2a8b21f5
Autor:
Bas van de Waterbeemd, Gijsbert Zomer, Jan van den Ijssel, Lonneke van Keulen, Michel H Eppink, Peter van der Ley, Leo A van der Pol
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54314 (2013)
Outer membrane vesicles (OMV) contain immunogenic proteins and contribute to in vivo survival and virulence of bacterial pathogens. The first OMV vaccines successfully stopped Neisseria meningitidis serogroup B outbreaks but required detergent-extrac
Externí odkaz:
https://doaj.org/article/fef846d00b9043988082da0ff14b3826
Autor:
Gerwin D Rodenburg, Floris Fransen, Debby Bogaert, Kim Schipper, Rolf H H Groenwold, Hendrik Jan Hamstra, Brenda M Westerhuis, Diederik van de Beek, Peter van der Ley, Elisabeth A M Sanders, Arie van der Ende
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49295 (2012)
BACKGROUND: Meningococci produce a penta-acylated instead of hexa-acylated lipid A when their lpxL1 gene is inactivated. Meningococcal strains with such lipid A endotoxin variants have been found previously in adult meningitis patients, where they ca
Externí odkaz:
https://doaj.org/article/51c764711b114a00b4cb7bb3e75173bd